Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Westwood Pharmaceuticals was a prominent American pharmaceutical company specializing in dermatological products and therapeutic skin care. Founded in Buffalo, New York, the company was acquired by Bristol-Myers in 1959 and later merged with Squibb's dermatology unit to form Westwood-Squibb. The firm was widely recognized for its portfolio of consumer and prescription brands, including Lac-Hydrin, Keri Lotion, and PreSun. Its research and development efforts focused on treating conditions such as acne, psoriasis, and xerosis through innovative topical formulations. Although it no longer operates as an independent entity, its legacy remains significant in the history of dermatological medicine. Many of its former products continue to be marketed under various corporate umbrellas today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Westwood Pharmaceuticals.